NasdaqCM:APLTBiotechs
Are Applied Therapeutics' (APLT) Narrowing Losses a Turning Point for Its Strategic Vision?
Applied Therapeutics released its third quarter 2025 earnings, reporting revenue of US$1 million and a net loss of US$18.99 million, both improved from the previous year; the company also announced Executive Chairman John Johnson's resignation for personal reasons.
The sizable reduction in net losses and increased revenue, alongside leadership changes unconnected to business issues, may shape future corporate priorities.
We'll explore how Applied Therapeutics' narrowing quarterly losses...